SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001424422-19-000010
Filing Date
2019-07-18
Accepted
2019-07-18 17:31:14
Documents
1
Period of Report
2019-07-16

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2131
  Complete submission text file 0001424422-19-000010.txt   3519
Mailing Address 115 NICHOLSON LANE SAN JOSE CA 95134
Business Address 115 NICHOLSON LANE SAN JOSE CA 95134 650-889-5020
BioPharmX Corp (Issuer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7 KITCHELL RD. MORRISTOWN NJ 07960
Business Address
Bosacki Steven (Reporting) CIK: 0001782878 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37411 | Film No.: 19961985